Why the study?
Does oral estradiol improve the myocardial performance index in hypertensive postmenopausal women?
Does oral estradiol improve the myocardial performance index in hypertensive postmenopausal women?
Oral estradiol replacement therapy over 12 weeks significantly improves the myocardial performance index and diastolic function parameters in hypertensive postmenopausal women.
No takes yet. Share an insight, caveat, or question.
Supports short-term oral estradiol for diastolic function in hypertensive postmenopausal women; extends RCT evidence on menopausal hormone therapy.
Aldrighi et al. (2004) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: